tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market
Want to see GB:STX full AI Analyst Report?

Shield Therapeutics (STX) Technical Analysis

42 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.58, suggesting Shield Therapeutics PLC is a Buy.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 7.49, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 8.23, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

May 21, 2026, 12:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.02
6.28
6.47
6.73
6.92
7.18
7.37
Fibonacci
6.28
6.46
6.56
6.73
6.91
7.01
7.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

May 21, 2026, 12:44 AM
Period
Simple
Exponential
MA5
6.78Sell
6.76Sell
MA10
6.82Sell
7.01Sell
MA20
7.75Sell
7.49Sell
MA50
8.23Sell
8.23Sell
MA100
9.31Sell
8.53Sell
MA200
8.55Sell
7.60Sell
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 7.01, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 8.53, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.
Shield Therapeutics PLC’s (STX) stock price is 9.85 p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 8.23, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85 p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 9.31, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85 p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 8.55, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

May 21, 2026, 12:44 AM
Name
Value
Implied Action
RSI (14)
25.82
Buy
STOCH (9,6)
27.23
Neutral
STOCHRSI (14)
10.31
Buy
MACD (12,26)
-0.58
Buy
ADX (14)
34.70
Neutral
Williams %R
-91.09
Buy
CCI (14)
-73.40
Neutral
ATR (14)
0.49
-
Ultimate Oscillator
46.42
Neutral
ROC
-24.86
Sell
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 25.82, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 34.70, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is -73.40, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is -24.86, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Sell.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 25.82, which suggests STX is a Buy.
      What is STX’s MACD?
      STX’s MACD is -0.58, which suggests STX is a Buy.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 6.78, which suggests STX is a Sell.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 7.75, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 8.23, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 8.55, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -91.09, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -73.40, which suggests STX is a Neutral.
                    What is the share price of Shield Therapeutics PLC?